Physician

Charles Leroy Clark, M.D.

According to 2025 Medicare claims, Charles Clark, M.D. (NPI: 1912158627) practices ophthalmology in the San Angelo, TX market, with the plurality of this provider's patient population coming from Tom Green, TX. This provider's primary affiliated billing organization is OPHTHALMOLOGY SPECIALISTS OF TEXAS, PLLC (NPI: 1902836166; TIN: 450466456) and primary practice location at 79606-1224. Clark is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974), Main Street Rural Health Magnolia ACO LLC (ACO ID: A5400), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Clark's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,015 traditional Medicare patients, billed 29,819 HCPCS/CPT codes, and received $2,849,278 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 1,260 prescription claims across 232 beneficiaries totaling $50,753 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 3 records totaling $1,066. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $706,971 to $2,849,278. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $40,410 and ending at $50,753. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	698	5,876	$706,971
2016	1,013	12,335	$1,618,107
2017	1,024	6,582	$723,266
2018	444	4,511	$473,659
2019	598	5,285	$607,496
2020	694	5,844	$774,638
2021	844	7,817	$1,131,739
2022	909	9,562	$1,362,717
2023	952	21,162	$2,170,336
2024	1,015	29,819	$2,849,278

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	151	602	$40,410
2016	229	1,050	$67,864
2017	167	573	$35,395
2018	96	427	$32,497
2019	112	484	$29,853
2020	112	426	$29,806
2021	141	567	$35,484
2022	197	933	$54,654
2023	207	1,012	$55,565
2024	232	1,260	$50,753

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	293	317	$120
92014	Established patient complete exam of visual system	717	1,127	$98
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	742	1,799	$89
67028	Injection of drug into eye	318	2,065	$88
92134	Imaging of retina	989	3,402	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	256	6,361	$6,969
Lumigan	Bimatoprost	13	1,027	$5,395
Alphagan P	Brimonidine Tartrate	21	857	$5,043
Ketorolac Tromethamine	Ketorolac Tromethamine	134	3,019	$4,218
Fluorometholone	Fluorometholone	21	565	$2,532

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$47	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$1,019	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Leroy Clark, M.D.?

Tedicare shows public-source Medicare data for Charles Leroy Clark, M.D. (NPI 1912158627), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Leroy Clark, M.D. have ACO affiliation data?

Charles Leroy Clark, M.D. is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974), Main Street Rural Health Magnolia ACO LLC (MSSP, ACO ID A5400), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Charles Leroy Clark, M.D.?

Charles Leroy Clark, M.D. is linked to OPHTHALMOLOGY SPECIALISTS OF TEXAS, PLLC (billing NPI 1902836166) in the available physician profile data.

Does Charles Leroy Clark, M.D. have Open Payments data?

Charles Leroy Clark, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.